Stanley Druckenmiller – LLY history
- Issuer:
- Eli Lilly & Co
- Quarters tracked:
- 14 (Q2 2022 → Q2 2026)
- Current shares:
- 12,380
- Current value:
- $14.85M
- Peak shares:
- 737,725 (Q4 2022)
- Overall change:
- -96%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q2 2026 | 12,380 | $14.85M | $1199.43 | +12,380 | +100% |
| Q3 2025 | SOLD | — | — | -100,675 | -100% |
| Q2 2025 | 100,675 | $78.48M | $779.53 | +5,845 | +6% |
| Q1 2025 | 94,830 | $78.32M | $825.91 | +32,640 | +52% |
| Q4 2024 | 62,190 | $48.01M | $772.01 | +62,190 | +100% |
| Q2 2024 | SOLD | — | — | -61,664 | -100% |
| Q1 2024 | 61,664 | $47.97M | $777.96 | -340,886 | -85% |
| Q4 2023 | 402,550 | $234.65M | $582.92 | -51,565 | -11% |
| Q3 2023 | 454,115 | $243.92M | $537.13 | -82,330 | -15% |
| Q2 2023 | 536,445 | $251.58M | $468.98 | -69,765 | -12% |
| Q1 2023 | 606,210 | $208.19M | $343.42 | -131,515 | -18% |
| Q4 2022 | 737,725 | $269.89M | $365.84 | +252,830 | +52% |
| Q3 2022 | 484,895 | $156.79M | $323.35 | +187,745 | +63% |
| Q2 2022 | 297,150 | $96.34M | $324.23 | — | NEW |